Research Interests
Open to PhD applications in the field of:
- Stimuli-responsive nanomedicines
- Biologics (RNA and proteins) delivery
- Exosomes and exosome mimetics
- Immunotherapy
- Tumour microenvironment
- Targeted delivery
- Theranostics
- Microfluidics
Current Research Opportunities
Public outreach & key achievements
- Prostate Cancer Photos competition 2019
- Developing new nanomedicine for advanced prostate cancer
- GSK Emerging Scientist Award for nanomedicine research
- Nanomedicine: promises and challenges for the future of public health
Research students
Name: Ms Raghed Qadadeh
PhD title: RNA lipid nanoparticles targeting tumour microenvironment
Years of Study: 2022-2025
Country: Jordan
Name: Ms Minao Zhang
PhD title: Molecularly imprinted nanoparticles for cancer immunotherapy
Years of Study: 2022-2025
Country: China
Name: Ms Sophie Griffith
PhD title: Designing dually responsive lipid nanoparticles for nucleic acid delivery
Years of Study: 2021-2024
Country: Northern Ireland
Name: Mr Hamoud Alotaibi
PhD title: Engineering biodegradable nanoparticles for photothermal therapy
Years of Study: 2021-2024
Country: Saudi Arabia
Name: Ms Siyang Wu
PhD title: Developing multifunctional nanocapsules for skin cancer
Years of Study: 2020-2023
Country: China
Name: Ms Ubah Abdi
PhD title: Developing nanomedicines for pancreatic cancer
Years of Study: 2019-2023
Country: UK-Wales
Name: Mr Matt Barker
PhD title: Engineering an ICD stimulated dendritic cell derived exosome-mimetic vaccine against cancer antigens
Years of Study: 2018-2022
Country: UK-England
Alumni: Where are they now
Name: Dr Calvin Cheung
PhD Title: Preparation of multifunctional nanoparticles using microfluidics
Year of Study: 2016-2020
Country: Hong Kong
Current position: Formulation Scientist, Nano and Advanced Materials Institute Limited, Hong Kong
Name: Dr Sara Pereira
PhD title: Developing a thermoresponsive targeted nanomedicine for advanced prostate cancer
Years of Study: 2014-2019 (part-time)
Country: Portugal
Current position: Senior Scientist, AstraZeneca, Cambridge, UK
Name: Dr Vera Silva
PhD title: Development of Novel Cupric- Tirapazamine Liposomes for Hypoxia Selective Therapy
Years of Study: 2014-2017
Country: Portugal
Current position: Oncology Scientist at Engitix Therapeutics, UK
Discover More
- Prostate Cancer Photos competition 2019
- Developing new nanomedicine for advanced prostate cancer
- GSK Emerging Scientist Award for nanomedicine research
- Nanomedicine: promises and challenges for the future of public health